Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease

• Yagahira E. Castro-Sesquen,

  Affiliations Department of International Health, Johns Hopkins University, Bloomberg School of Hygiene and Public Health, Baltimore, Maryland, United States of America, Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru

  ⨯
• Robert H. Gilman ,

  * E-mail: gilmanbob@gmail.com

  Affiliation Department of International Health, Johns Hopkins University, Bloomberg School of Hygiene and Public Health, Baltimore, Maryland, United States of America

  ⨯
• Gerson Galdos-Cardenas,

  Affiliation Department of International Health, Johns Hopkins University, Bloomberg School of Hygiene and Public Health, Baltimore, Maryland, United States of America

  ⨯
• Lisbeth Ferrufino,

  Affiliation Hospital Universitario Japonés, Santa Cruz, Bolivia

  ⨯
• Gerardo Sánchez,

  Affiliation Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru

  ⨯
• Edward Valencia Ayala,

  Affiliation Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru

  ⨯
• Lance Liotta,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, Virginia, United States of America

  ⨯
• Caryn Bern,

  Affiliation Global Health Sciences, Department of Epidemiology and Biostatistics School of Medicine, University of California, San Francisco, California, United States of America

  ⨯
• Alessandra Luchini,

  Affiliation Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, Virginia, United States of America

  ⨯
• the Working Group on Chagas Disease in Bolivia and Peru

  ¶Membership of the Working Group on Chagas Disease in Bolivia and Peru is provided in the Acknowledgments.

  ⨯